As FABP4-positive tumor cells were mainly located in regions that often interacted with adipose tissue (Fig. 2K), we further determined whether FABP4 expression at the tumor/adipose tissue border (Fig. 4H, I) impacted clinical parameters. This evidence concerns the gene FABP4 and neoplasm.